No Data
Gilead Sciences Declares $0.77 Dividend
Seeking Alpha58minutes ago
Applied Dna Sciences, OptimizeRx, SCWorx Among Healthcare Movers
Seeking Alpha10:00 ET
Morgan Stanley Adjusts Price Target on Gilead Sciences to $78 From $80
Gilead Sciences (GILD) has an average rating of outperform and price targets ranging from $69 to $121, according to analysts polled by Capital IQ. Price: 64.76, Change: -0.51, Percent Change: -0.78
MT Newswires09:59 ET
Earnings Call Summary | Gilead Sciences(GILD.US) Q1 2024 Earnings Conference
The following is a summary of the Gilead Sciences, Inc. (GILD) Q1 2024 Earnings Call Transcript:Financial Performance:Gilead's Q1 total product sales, excluding Veklury, grew 6% year-over-year to $6.1
moomoo AI09:13 ET · Conference Call
Quest Diagnostics Foundation and Green Bronx Machine Expand Collaboration to Bring Acclaimed Indoor Gardening Curriculum to More Communities and Raise Awareness for Impact of Nutrition Education on Health Equity
Foundation grant will help NYC-based nonprofit expand reach of its innovative curriculum to 50 schools in Baltimore and Houston; funding will also support film screening tour of award-winning document
Accesswire08:45 ET
Analysts Are Bullish on Top Healthcare Stocks: Regeneron (REGN), Gilead Sciences (GILD)
TipRanks08:21 ET